fbpx
  • Home
  • Study Details
Open

PREVENT-COVID: A Study for IBD Patients who have Received a COVID-19 Vaccine

The purpose of this study is to learn more about how well the COVID-19 vaccine works for patients with IBD. This includes people with Crohn's disease and ulcerative colitis. We want to learn more about side effects, and whether the vaccine impacts IBD activity. This study does not provide the COVID-19 vaccine and is only for people who have already received at least 1 vaccine.

Age & Gender

  • 16 years ~ 99 years
  • Male, Female, Gender Inclusive

Location

United States (Nationwide)

What will be asked of you

There will be 8 surveys for you to take over the course of the study. In these surveys, we will ask you some questions about yourself, your IBD, and your IBD medications. We will also ask you to provide some information about your COVID-19 vaccine, including any side effects you may have experienced. You will have the option to complete 2 blood draws to check your antibody response to the vaccine, these results will be returned to you after each blood draw.

Incentives

Up to $130 if you complete all aspects of the study

Total length of participation:
18 months

Looking for Specific Volunteers

Able to participate:

  • You have been diagnosed with IBD, including Crohn's Disease or Ulcerative Colitis
  • You have received your first COVID-19 vaccine in the past 60 days
  • You live in the United States

Not eligible if:

  • You are not willing to stay in the study for 18 months

Contact the Team

Visit Location

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Kimberly Weaver
Pediatrics - Gastroenterology

Study Type

Clinical or Medical
Observational

Study Topics

Chronic Conditions
Stomach, Digestion and Gut Health
Immune System/Infections
COVID-19

IRB Number

21-0301

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.